- Home
- ATEX vs CYRX Comparison
ATEX vs CYRX Comparison
Compare ATEX & CYRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATEX
- CYRX
- Stock Information
- Founded
- ATEX 1997
- CYRX 1999
- Country
- ATEX United States
- CYRX United States
- Employees
- ATEX N/A
- CYRX N/A
- Industry
- ATEX Telecommunications Equipment
- CYRX Biotechnology: Pharmaceutical Preparations
- Sector
- ATEX Telecommunications
- CYRX Health Care
- Exchange
- ATEX Nasdaq
- CYRX Nasdaq
- Market Cap
- ATEX 381.9M
- CYRX 438.7M
- IPO Year
- ATEX N/A
- CYRX N/A
- Fundamental
- Price
- ATEX $19.57
- CYRX $10.75
- Analyst Decision
- ATEX Buy
- CYRX Strong Buy
- Analyst Count
- ATEX 2
- CYRX 9
- Target Price
- ATEX $58.50
- CYRX $12.56
- AVG Volume (30 Days)
- ATEX 202.4K
- CYRX 679.6K
- Earning Date
- ATEX 11-12-2025
- CYRX 11-04-2025
- Dividend Yield
- ATEX N/A
- CYRX N/A
- EPS Growth
- ATEX N/A
- CYRX N/A
- EPS
- ATEX 1.58
- CYRX 1.35
- Revenue
- ATEX $5,924,000.00
- CYRX $237,879,000.00
- Revenue This Year
- ATEX N/A
- CYRX N/A
- Revenue Next Year
- ATEX $5.18
- CYRX $9.20
- P/E Ratio
- ATEX $12.46
- CYRX $8.00
- Revenue Growth
- ATEX 15.97
- CYRX 24.93
- 52 Week Low
- ATEX $19.26
- CYRX $4.58
- 52 Week High
- ATEX $42.91
- CYRX $11.44
- Technical
- Relative Strength Index (RSI)
- ATEX 35.65
- CYRX 63.00
- Support Level
- ATEX $19.26
- CYRX $9.70
- Resistance Level
- ATEX $20.98
- CYRX $10.66
- Average True Range (ATR)
- ATEX 0.77
- CYRX 0.65
- MACD
- ATEX -0.20
- CYRX 0.06
- Stochastic Oscillator
- ATEX 11.25
- CYRX 79.22
About ATEX Anterix Inc.
Anterix Inc is a United States-based company engaged in delivering broadband needed to modernize infrastructure for energy, transportation, logistics, and other industries. The company offers Private LTE for utilities which help to automate processes, monitor environmental conditions, enable artificial intelligence, and drive productivity.
About CYRX CryoPort Inc.
CryoPort Inc is a leader serving the life sciences industry as a provider of integrated temperature-controlled supply chain solutions supporting the life sciences in the biopharma/pharma, animal health, and reproductive medicine markets. It operates in two reportable segments: Life Sciences Services and Life Sciences Products. Geographically the company operates in the Americas, Europe, the Middle East and Africa (EMEA), and Asia Pacific (APAC), generating a majority of its revenue from the Americas.